Susquehanna Fundamental Investments’s bluebird bio BLUE Stock Holding History

Susquehanna Fundamental Investments’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-9,471	Closed	-$602K	–	665
2023 Q1	$602K	Hold	9,471	–	–	0.01%	635
2022 Q4	$1.31M	Buy	+9,471	New	+$1.33M	0.02%	588
2020 Q4	–	Sell	-934	Closed	-$653K	–	1497
2020 Q3	$653K	Sell	934 -402	-30%	-$314K	0.02%	787
2020 Q2	$1.06M	Buy	+1,336	New	+$1.01M	0.05%	444

Other funds holding BLUE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Susquehanna Fundamental Investments's BLUE Position: Q2 2023 in Review

Susquehanna Fundamental Investments sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 9,471 shares — an estimated $602K sold.

Susquehanna Fundamental Investments first reported a position in BLUE in Q2 2020 and held it in 4 quarters. The position peaked at $1.31M in Q4 2022. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

Susquehanna Fundamental Investments reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
Susquehanna Fundamental Investments sold 9,471 bluebird bio shares in Q2 2023, an estimated $602K.
Susquehanna Fundamental Investments first reported a position in bluebird bio in Q2 2020 and held it in 4 quarters.
Susquehanna Fundamental Investments's bluebird bio position peaked at $1.31M in Q4 2022.
175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2023, filed 11 Aug 2023.